The Economist

Donald Trump is waging war on sky-high drug prices. Can he win?

Title: Donald Trump Declares War on Soaring Drug Costs. Is Victory Possible?

Rewrite:

Big pharmaceutical companies in the United States are confronting a critical moment

Donald Trump has initiated an aggressive campaign against the exorbitant costs of pharmaceuticals, raising the question of whether he can succeed in curbing these expenses. As the former president targets the high prices charged by major drug manufacturers, the pharmaceutical industry in America is facing a significant challenge. The central issue remains whether Trump’s efforts will be enough to secure victory in this ongoing battle over medication affordability.


Source: The Economist Generated at: 2025-09-28 11:30:19 UTC

Related Articles

Bloomberg

Lebanon Tensions, Commerzbank's 30% UniCredit Stake, More

Lebanon faces rising tensions as Commerzbank acquires a 30% stake in UniCredit, marking significant geopolitical and fin...

Bloomberg

Stock Movers: STMicro, Prosus, Abivax (Podcast)

Bloomberg’s Stock Movers podcast analyzes market activity for STMicroelectronics, Prosus, and Abivax.

Bloomberg

Trump Aims to Calm Lebanon Tension, Russia-Ukraine Strikes, More

Trump aims to de-escalate Lebanon tensions and address Russia-Ukraine strikes, per Bloomberg.

Bloomberg

Lebanon Tensions, Major Strikes on Ukraine, More

Escalating tensions in Lebanon and significant strikes in Ukraine dominate the news, alongside other developing global e...

Bloomberg

Trump-Netanyahu Split, Alphabet To Raise $80B, More

Trump and Netanyahu diverge, while Alphabet plans an $80B raise. These are key updates from Bloomberg.

Financial Times

British Land picks Canadian pension fund executive as next boss

British Land appoints Canadian pension executive Joanne McNamara as its next CEO, making her one of the few women to lea...